CRYL1_PIG
ID CRYL1_PIG Reviewed; 322 AA.
AC Q8SQ26;
DT 18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT 23-JAN-2007, sequence version 3.
DT 03-AUG-2022, entry version 83.
DE RecName: Full=Lambda-crystallin homolog;
DE EC=1.1.1.45 {ECO:0000250|UniProtKB:Q9Y2S2};
DE AltName: Full=L-gulonate 3-dehydrogenase;
DE Short=Gul3DH;
GN Name=CRYL1; Synonyms=CRY;
OS Sus scrofa (Pig).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX NCBI_TaxID=9823;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RX PubMed=12527201; DOI=10.1016/s0378-1119(02)01095-8;
RA Chen J., Yu L., Li D., Gao Q., Wang J., Huang X., Bi G., Wu H., Zhao S.;
RT "Human CRYL1, a novel enzyme-crystallin overexpressed in liver and kidney
RT and downregulated in 58% of liver cancer tissues from 60 Chinese patients,
RT and four new homologs from other mammalians.";
RL Gene 302:103-113(2003).
CC -!- FUNCTION: Has high L-gulonate 3-dehydrogenase activity. It also
CC exhibits low dehydrogenase activity toward L-3-hydroxybutyrate (HBA)
CC and L-threonate. {ECO:0000250|UniProtKB:Q9Y2S2}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=L-gulonate + NAD(+) = 3-dehydro-L-gulonate + H(+) + NADH;
CC Xref=Rhea:RHEA:12889, ChEBI:CHEBI:13115, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:57540, ChEBI:CHEBI:57655, ChEBI:CHEBI:57945; EC=1.1.1.45;
CC Evidence={ECO:0000250|UniProtKB:Q9Y2S2};
CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12890;
CC Evidence={ECO:0000250|UniProtKB:Q9Y2S2};
CC -!- ACTIVITY REGULATION: Inhibited by malonate.
CC {ECO:0000250|UniProtKB:Q9Y2S2}.
CC -!- SUBUNIT: Homodimer. {ECO:0000250|UniProtKB:Q9Y2S2}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P14755}.
CC -!- SIMILARITY: Belongs to the 3-hydroxyacyl-CoA dehydrogenase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AF351608; AAM13397.1; -; mRNA.
DR RefSeq; NP_999046.1; NM_213881.1.
DR AlphaFoldDB; Q8SQ26; -.
DR SMR; Q8SQ26; -.
DR STRING; 9823.ENSSSCP00000009883; -.
DR PaxDb; Q8SQ26; -.
DR PeptideAtlas; Q8SQ26; -.
DR GeneID; 396914; -.
DR KEGG; ssc:396914; -.
DR CTD; 51084; -.
DR eggNOG; KOG2305; Eukaryota.
DR InParanoid; Q8SQ26; -.
DR OrthoDB; 840631at2759; -.
DR Proteomes; UP000008227; Unplaced.
DR Proteomes; UP000314985; Unplaced.
DR GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR GO; GO:0050104; F:L-gulonate 3-dehydrogenase activity; ISS:UniProtKB.
DR GO; GO:0070403; F:NAD+ binding; ISS:UniProtKB.
DR GO; GO:0016491; F:oxidoreductase activity; IBA:GO_Central.
DR GO; GO:0006631; P:fatty acid metabolic process; IEA:InterPro.
DR Gene3D; 1.10.1040.10; -; 1.
DR InterPro; IPR022694; 3-OHacyl-CoA_DH.
DR InterPro; IPR006176; 3-OHacyl-CoA_DH_NAD-bd.
DR InterPro; IPR006108; 3HC_DH_C.
DR InterPro; IPR008927; 6-PGluconate_DH-like_C_sf.
DR InterPro; IPR013328; 6PGD_dom2.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR Pfam; PF00725; 3HCDH; 1.
DR Pfam; PF02737; 3HCDH_N; 1.
DR PIRSF; PIRSF000105; HCDH; 1.
DR SUPFAM; SSF48179; SSF48179; 1.
DR SUPFAM; SSF51735; SSF51735; 1.
PE 2: Evidence at transcript level;
KW Cytoplasm; NAD; Oxidoreductase; Phosphoprotein; Reference proteome.
FT CHAIN 1..322
FT /note="Lambda-crystallin homolog"
FT /id="PRO_0000232506"
FT BINDING 19..20
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 39
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 100
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT BINDING 105
FT /ligand="NAD(+)"
FT /ligand_id="ChEBI:CHEBI:57540"
FT /evidence="ECO:0000250"
FT MOD_RES 6
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:Q811X6"
SQ SEQUENCE 322 AA; 35128 MW; 13574ABCA10945DC CRC64;
MASSASSTAD GVAVVGSGLI GRSWAMLFAS GGFRVKLYDI EQQQVTGALD TIRKEMKLLE
QSGALKGSLG AEEQLALISG CSDLREAVEG TVHIQECVPE NLELKQQLFA QLDQIVDGNV
VLSSSSSCLL PSKLFAGLVH VRQCLVAHPV NPPYHVPLVE LVPHPETAPA TMARTYALMR
QIGQSPVRIL KEVDGFALNR LQYALIGEAW RLVEARIVSP GDLDLVMSDG LGLRYAFIGP
LETMHLNAEG MLSYCDRYRE GMKRVLKTFG PIPEFSGAVA EKVHQAMCVK VPDDPEHLSA
RREWRDGCLM RLAKLKGQVQ PP